Business Context and Reporting Period
Company: Owens & Minor, Inc. (Note: Input metadata referenced "Accendra Health Inc," but the filing text is for Owens & Minor, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2009
Business Overview: Owens & Minor is a distributor of medical and surgical supplies to the acute-care market. In January 2009, the company exited its direct-to-consumer (DTC) distribution business, which is now reported as discontinued operations. The company acquired The Burrows Company in October 2008, which contributed significantly to revenue growth in the current period.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Sep 30, 2009 | 9 Months Ended Sep 30, 2009 |
|---|---|---|
| Revenue | $2,034,792 | $5,997,200 |
| Gross Margin | $204,342 (10.04%) | $585,674 (9.77%) |
| Operating Earnings | $56,692 (2.79%) | $145,518 (2.43%) |
| Net Income | $34,687 | $72,311 |
| Diluted EPS (Continuing Ops) | $0.83 | $2.03 |
| Cash from Operating Activities | N/A | $161,460 |
| Cash and Equivalents (Sep 30, 2009) | $42,931 | |
| Long-Term Debt | $207,999 | |
| Available Credit Facility | $295,000 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 13.9% in Q3 2009 and 13.5% for the nine months ended Sep 30, 2009, compared to 2008. Approximately 60-65% of this growth is attributed to the acquisition of The Burrows Company and other net new business.
- Profitability: Operating earnings increased to $56.7 million in Q3 2009 from $46.3 million in Q3 2008. Net income for the nine months ended Sep 30, 2009, was $72.3 million, a slight decrease from $73.1 million in the prior year, primarily due to a $12.5 million loss from discontinued operations in 2009.
- Discontinued Operations: The company exited its DTC business in January 2009. This resulted in a $12.5 million pre-tax loss for the nine-month period, offset partially by a $3.2 million gain on the sale of assets to Liberty Healthcare Group.
- Interest Expense: Net interest expense decreased significantly in 2009 ($9.8 million for nine months) compared to 2008 ($12.7 million), largely because the 2008 period included a $3.1 million loss from the termination of interest rate swaps.
- Liquidity: Cash and cash equivalents increased by $35.0 million to $42.9 million, driven by strong operating cash flow ($161.5 million) and proceeds from the sale of the DTC business ($63.0 million), which were used to pay down the revolving credit facility by $150.6 million.
Guidance, Outlook, and Risks
Management Commentary: Management attributes improved operating earnings to increased revenues from the Burrows acquisition and net new business. Gross margin percentage improved in Q3 2009 due to supplier price reductions (resulting in an $11.5 million LIFO credit) and the recognition of revenue from customer contracts. SG&A expenses increased due to costs associated with the Burrows acquisition and serving new customers.
Capital Resources: The company maintains a $306 million revolving credit facility with $295 million available. It also has $200 million in senior notes maturing in 2016 at 6.35% interest. Management believes current financing sources are sufficient for working capital and strategic growth.
Risks and Contingencies:
- Market Risk: Exposure to interest rate fluctuations on the revolving credit facility and credit risk from customer nonpayment (DSO was 23.0 days).
- Regulatory and Economic: Risks include changes in healthcare laws, general economic conditions, and dependence on sales to certain customers.
- Contractual Obligations: The company has $5.9 million in contingent obligations related to customer performance targets, though none are currently accrued as they are not considered probable.
- Tax Matters: A lower effective tax rate in 2009 (35.2% in Q3) was driven by $1.7 million in tax benefits from the conclusion of IRS audits for 2006 and 2007 returns.
Investor Verification Checklist
- Acquisition Integration: Verify the ongoing financial performance and integration costs associated with The Burrows Company acquisition.
- Discontinued Operations: Confirm the finalization of the DTC business exit and ensure no further material charges are expected.
- Debt Covenants: Review the leverage ratio and compliance with the revolving credit facility terms, noting the facility expires in May 2011.
- Supplier Pricing: Assess the sustainability of the gross margin improvement driven by supplier price reductions and LIFO credits.
- Customer Concentration: Evaluate the risk associated with dependence on sales to specific customers and their ability to meet financial commitments.